Meta-analysis of ifosfamide-based combination chemotherapy in advanced soft tissue sarcoma

Cancer Treatment Reviews

Volumn 34, Issue 4, 2008, Pages 339-347

  Verma, Shailendra ^a   Younus, Jawaid ^b   Stys Norman, Denise ^c   Haynes, Adam E ^c   Blackstein, Martin ^d  

^a UNIVERSITY OF OTTAWA   (Canada)

^b LONDON REGIONAL CANCER PROGRAM   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

^d MOUNT SINAI HOSPITAL   (Canada)

Author keywords

Chemotherapy; Ifosfamide; Meta analysis; Soft tissue sarcoma

Indexed keywords

AMPHOTERICIN B; ANTHRACYCLINE; CISPLATIN; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; EPIRUBICIN; IFOSFAMIDE; MITOMYCIN; VINCRISTINE;

ADD ON THERAPY; ADVANCED CANCER; BONE MARROW SUPPRESSION; CANCER COMBINATION CHEMOTHERAPY; CARDIOTOXICITY; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTINUOUS INFUSION; DRUG DOSE REDUCTION; DRUG FATALITY; DRUG INDICATION; DRUG RESPONSE; FEBRILE NEUTROPENIA; GRANULOCYTOPENIA; HEART DISEASE; HEMATURIA; HUMAN; INOPERABLE CANCER; KIDNEY FAILURE; LEUKOPENIA; META ANALYSIS; METASTASIS; MONOTHERAPY; NAUSEA AND VOMITING; NEPHROTOXICITY; NEUROTOXICITY; NEUTROPENIA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; QUALITY OF LIFE; REVIEW; SEPSIS; SIDE EFFECT; SOFT TISSUE SARCOMA; SURVIVAL TIME; SYSTEMATIC REVIEW; THROMBOCYTOPENIA;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CLINICAL TRIALS, PHASE III AS TOPIC; HUMANS; IFOSFAMIDE; NEOPLASM METASTASIS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SARCOMA; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 43949084697     PISSN: 03057372     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ctrv.2008.01.005     Document Type: Review

References (37)

1. Frost D.B. Pulmonary metastasectomy for soft tissue sarcomas: is it justified?. J Surg Oncol 59 (1995) 110-115
2. van Geel A.N., Pastorino U., Jauch K.W., Judson I.R., van Coevorden F., Buesa J., et al. Surgical treatment of lung metastases: the European Organization for Research and Treatment of Cancer soft tissue and bone sarcoma group study of 255 patients. Cancer 77 (1996) 675-682
3. Bramwell V.H.C., Anderson D., Charette M., and The Cancer Care Ontario Practice Guidelines Initiative Sarcoma Disease Site Group. Doxorubicin-based chemotherapy for the palliative treatment of adult patients with locally-advanced or metastatic soft-tissue sarcoma: a meta-analysis and clinical practice guideline. Sarcoma 4 (2000) 103-112
4. Vanhoefer U., Schleucher N., Klaassen U., Seeber S., and Harstrick A. Ifosfamide-based drug combinations: preclinical evaluation of drug interactions and translation into the clinic. Semin Oncol 27 Suppl. 1 (2000) 8-13
5. Yalçin S., Güllü I., Barişta I., Tekuzman G., Özişik Y., Çelik I., et al. Treatment of advanced refractory sarcomas with ifosfamide and etoposide combination chemotherapy. Cancer Invest 16 (1998) 297-302
6. Antman K.H., Ryan L., Elias A., Sherman D., and Grier H.E. Response to ifosfamide and mesna: 124 previously treated patients with metastatic or unresectable sarcoma. J Clin Oncol 7 (1989) 126-131
7. Bramwell V.H.C., Mouridsen H.T., Santoro A., Blackledge G., Somers R., Verweij J., et al. Cyclophosphamide versus ifosfamide: a randomized phase II trial in adult soft-tissue sarcomas. Cancer Chemother Pharmacol 31 Suppl. 2 (1993) S180-S184
8. Stuart-Harris R.C., Harper P.G., Parsons C.A., Kaye S.B., Mooney C.A., Gowing N.F., et al. High-dose alkylation therapy using ifosfamide infusion with mesna in the treatment of adult advanced soft-tissue sarcoma. Cancer Chemother Pharmacol 11 (1983) 69-72
9. Elias A., Ryan L.M., Aisner J., and Antman K. Mesna, doxorubicin, ifosfamide, dacarbazine (MAID) regimen for adults with advanced sarcoma. Semin Oncol 17 (1990) 41-49
10. Le Cesne A., Antoine E., Spielmann M., LeChevalier T., Brain E., Toussaint C., et al. High-dose ifosfamide: circumvention of resistance to standard-dose ifosfamide in advanced soft tissue sarcomas. J Clin Oncol 13 (1995) 1600-1608
11. van Oosterom A.T., Mouridsen H.T., Nielson O.S., Dombernowsky P., Krzemieniecki K., Judson I., et al. Results of randomised studies of the EORTC Soft Tissue and Bone Sarcoma Group (STBSG) with two different ifosfamide regimens in first- and second-line chemotherapy in advanced soft tissue sarcoma patients. Eur J Cancer 38 (2002) 2397-2406
12. Santoro A., Tursz T., Mouridsen H., Verweij J., Steward W., Somers R., et al. Doxorubicin versus CYVADIC versus doxorubicin plus ifosfamide in first-line treatment of advanced soft tissue sarcomas: a randomized study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group. J Clin Oncol 13 (1995) 1537-1545
13. Edmonson J.H., Ryan L.M., Blum R.H., Brooks J.S.J., Shiraki M., Frytak S., et al. Randomized comparison of doxorubicin alone versus ifosfamide plus doxorubicin or mitomycin, doxorubicin and cisplatin against advanced soft tissue sarcomas. J Clin Oncol 11 (1993) 1269-1275
14. Browman G.P., Levine M.N., Mohide E.A., Hayward R.S.A., Pritchard K.I., Gafni A., et al. The practice guidelines development cycle: a conceptual tool for practice guidelines development and implementation. J Clin Oncol 13 (1995) 502-512
15. Review Manager (RevMan) [computer program]. Oxford (England): Update Software; 2000.
16. Antman K., Crowley J., Balcerzak S.P., Rivkin S.E., Weiss G.R., Elias A., et al. An intergroup phase III randomized study of doxorubicin and dacarbazine with or without ifosfamide and mesna in advanced soft tissue and bone sarcomas. J Clin Oncol 11 (1993) 1276-1285
17. Comandone A., Bretti S., Bertetto O., Oliva C., Bergnolo P., and Bumma C. Low dose adriamycin and ifosfamide in the treatment of advanced adult soft tissue sarcomas. Anticancer Res 20 (2000) 2077-2080
18. Chevallier B., Leyvraz S., Olivier J.P., Fargeot P., Facchini T., and Vo Van M.L. Epirubicin and ifosfamide in advanced soft tissue sarcoma: a phase II study. Cancer Invest 11 (1993) 135-139
19. Schutte J., Mouridsen H., Steward W., Santoro A., van Oosterom A.T., Somers R., et al. Ifosfamide plus doxorubicin in previously untreated patients with advanced soft-tissue sarcoma. Cancer Chemother Pharmacol 31 (1993) S204-S209
20. Toma S., Palumbo R., Canavese G., Albanese E., Cantoni E., Barisone A., et al. Ifosfamide plus epirubicin at escalating doses in the treatment of locally-advanced and/or metastatic sarcomas. Cancer Chemother Pharmacol 31 (1993) S222-S227
21. Loehrer P.J., Sledge G.W., Nicaise C., Usakewicz J., Hainsworth J.D., Martelo O.J., et al. Ifosfamide plus doxorubicin in metastatic adult sarcomas: a multi-institutional phase II trial. J Clin Oncol 7 (1989) 1655-1659
22. Cantwell B.M.J., Carmichael J., Ghani S., and Harris A.L. A phase II study of ifosfamide/mesna with doxorubicin for adult soft tissue sarcoma. Cancer Chemother Pharmacol 21 (1988) 49-52
23. Mansi J.L., Fisher C., Wiltshaw E., MacMillan S., King M., and Stuart-Harris R. A phase I-II study of ifosfamide in combination with adriamycin in the treatment of adult soft tissue sarcoma. Eur J Cancer Clin Oncol 24 (1988) 1439-1443
24. González-Manzano R., Vieitez J.M., Tangco E., de Alava E.F., Herranz P., and Garcia-Foncillas J. Phase II evaluation of doxorubicin, ifosfamide and dacarbazine plus amphotericin B in the treatment of metastatic soft tissue sarcomas. Am J Clin Oncol 16 (1993) 332-337
25. Bokemeyer C., Harstrick A., Schmoll H.-J., Köhne-Wömpner C.H., Schöffski P., and Poliwoda H. Epirubicin/dacarbazine rapidly alternated with ifosfamide in the treatment of metastatic soft tissue sarcomas. Ann Oncol 3 (1992) 487-488
26. Bramwell V.H.C., Quirt I., Warr D., Verma S., Young V., Knowling M., et al. Combination chemotherapy with doxorubicin, dacarbazine, and ifosfamide in advanced adult soft tissue sarcoma. J Natl Cancer Inst 81 (1989) 1496-1499
27. Wiklund T.A., Blomqvist C.P., Virolainen M., and Elomaa I. Ifosfamide, vincristine, doxorubicin and dacarbazine in adult patients with advanced soft-tissue sarcoma. Cancer Chemother Pharmacol 30 (1992) 100-104
28. Shimizu Y. Combination of consecutive low-dose cisplatin with ifosfamide and epirubicin for sarcoma uteri [abstract]. Proc Am Soc Clin Oncol 21 (2002) 414a
29. Levy E., Thirion P., Gajewsky M., Le Mouel A., Gimonet J.F., Voisin M.C., et al. Phase II trial of ifosfamide, cisplatin and doxorubicin in advanced soft tissue sarcoma in adults [abstract]. Proc Am Soc Clin Oncol 17 (1998) 511a
30. Jäger E., Klein O., Wächter B., Bernhard H., Dippold W., Meyer zum Buschenfelde K.-H., et al. Combination of 5-fluorouracil, adriamycin, ifosfamide and cisplatin in metastatic adult soft tissue sarcoma: results of a phase II study. Oncology 53 (1996) 58-63
31. Frustaci S., Foladore S., Buonadonna A., De Paoli A., Crivellari D., Carbone A., et al. Epirubicin and ifosfamide in advanced soft tissue sarcomas. Ann Oncol 4 (1993) 669-672
32. Kawai A., Chuman H., Makimoto A., Ito Y., Yamaguchi U., Morimoto Y., et al. Ifosfamide - etoposide chemotherapy in patients with advanced adult soft tissue sarcomas [abstract]. Proc Am Soc Clin Oncol 23 (2004) 833s
33. Edmonson J.H., Buckner J.C., Long H.J., Loprinzi C.L., and Schaid D.J. Phase II study of ifosfamide-etoposide-mesna in adults with advanced nonosseous sarcomas. J Natl Cancer Inst 81 (1989) 863-866
34. Blair S.C., Zalupski M.M., and Baker L.H. Ifosfamide and etoposide in the treatment of advanced soft tissue sarcomas. Am J Clin Oncol 17 (1994) 480-484
35. Saeter G., Alvegård T.A., Monge O.R., Strander H., Turesson I., Klepp R., et al. Ifosfamide and continuous infusion etoposide in advanced adult soft tissue sarcoma. A Scandinavian Sarcoma Group phase II study. Eur J Cancer 33 (1997) 1551-1558
36. Pápai Z., Bodoky G., Szánto J., Poller I., Rahóty P., Eckhardt S., et al. The efficacy of a combination of etoposide, ifosfamide, and cisplatin in the treatment of patients with soft tissue sarcoma. Cancer 89 (2000) 177-180
37. Budd G.T., Metch B., Weiss S.A.W., Weick J.K., Fabian C., Stephens R.L., et al. Phase II trial of ifosfamide and cisplatin in the treatment of metastatic sarcomas: a Southwest Oncology Group study. Cancer Chemother Pharmacol 31 (1993) S213-S216